Travere Therapeutics Inc (NASDAQ: TVTX) kicked off on Friday, up 18.58% from the previous trading day, before settling in for the closing price of $29.65. Over the past 52 weeks, TVTX has traded in a range of $12.91-$30.97.
During the last 5-year period, the sales drop of Healthcare Sector giant was -3.34%. While this was happening, its average annual earnings per share was recorded 86.59%. With a float of $87.09 million, this company’s outstanding shares have now reached $89.46 million.
Let’s determine the extent of company efficiency that accounts for 385 employees.
Travere Therapeutics Inc (TVTX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Travere Therapeutics Inc is 2.67%, while institutional ownership is 121.77%. The most recent insider transaction that took place on Oct 31 ’25, was worth 629,693. Before that another transaction happened on Oct 31 ’25, when Company’s Officer proposed sale 5,591 for $35.00, making the entire transaction worth $195,685.
Travere Therapeutics Inc (TVTX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.47 earnings per share (EPS), lower than consensus estimate (set at -0.38) by -0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 86.59% per share during the next fiscal year.
Travere Therapeutics Inc (NASDAQ: TVTX) Trading Performance Indicators
Take a look at Travere Therapeutics Inc’s (TVTX) current performance indicators. Last quarter, stock had a quick ratio of 2.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.65 in one year’s time.
Technical Analysis of Travere Therapeutics Inc (TVTX)
Looking closely at Travere Therapeutics Inc (NASDAQ: TVTX), its last 5-days average volume was 2.87 million, which is a jump from its year-to-date volume of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 80.87%.
During the past 100 days, Travere Therapeutics Inc’s (TVTX) raw stochastic average was set at 99.16%, which indicates a significant increase from 98.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.23 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.51, while its 200-day Moving Average is $19.56. However, in the short run, Travere Therapeutics Inc’s stock first resistance to watch stands at $36.30. Second resistance stands at $37.43. The third major resistance level sits at $39.53. If the price goes on to break the first support level at $33.07, it is likely to go to the next support level at $30.97. Should the price break the second support level, the third support level stands at $29.84.
Travere Therapeutics Inc (NASDAQ: TVTX) Key Stats
The company with the Market Capitalisation of 3.15 billion has total of 89,139K Shares Outstanding. Its annual sales at the moment are 233,180 K in contrast with the sum of -321,550 K annual income. Company’s last quarter sales were recorded 114,450 K and last quarter income was -12,760 K.
